I Was Shocked at Who Is Now Running Berkshire Hathaway's $308 Billion Stock Portfolio

Greg Abel will bear ultimate responsibility for Berkshire's $308B equity portfolio and $373B in cash/short-term Treasuries, while Ted Weschler will manage roughly 6% of investments (leaving Abel responsible for ~94%). Abel lacks a public-equity track record, raising the probability Berkshire leans further toward whole-company acquisitions in insurance, energy and industrials rather than making large new public-stock bets. The change creates uncertainty around future capital-allocation style but does not signal an immediate elimination of stock investing.

Analysis

Greg Abel’s elevation tilts Berkshire’s marginal deployment mechanics toward whole-company M&A and operational integration rather than large passive stakes in mega-cap tech. Whole-company deals convert cash into operating ROIC rather than paper gains and will likely re-weight Berkshire’s return profile toward steady cash yields and cyclical industrial/energy upside over the next 12–36 months.

Immediate winners are pure-play participants and target-rich midcaps in insurance, energy, chemicals and industrials — these businesses see a demand shock for sell-side processes and can reprice on takeover premia; suppliers to those sectors will get a multiple uplift as buyers pay for vertical synergies. Conversely, large-cap public equities that rely on secular growth multiples (the biggest drivers of market cap appreciation over the last decade) become relatively less likely to be augmented by Berkshire’s balance sheet, creating a structural headwind to passive-index correlated allocations.

Key catalysts and risks: a single large, high-profile public-equity purchase by Berkshire would quickly reverse any underperformance thesis (days–weeks), while meaningful M&A cadence will take quarters to show book-value accretion and 12–36 months to affect EPS trajectory. The largest tail risk is management switching back to opportunistic stock-picking (via Weschler influence) or a major market dislocation that forces a reallocation back into liquid equities.

Contrarian angle: the market may underappreciate Abel’s operating skill in extracting ROIC from acquired assets — if he replicates past utility/industrial integration playbooks at scale, Berkshire’s intrinsic value could re-accelerate over a multi-year window, leaving a tactical opportunity to own a small, long-dated position that benefits from realized synergies.

Key Decisions for Investors

• Long NVDA — 6–12 month trade. Size 2–4% portfolio. Target +35–45% total return, stop -20%. Rationale: secular AI exposure continues to out-earn conglomerate-deployed capital if Berkshire reduces large-cap allocations; asymmetric upside vs Berkshire underweight risk.
• Long OXY — 12–24 month trade. Size 1–3% portfolio. Target +30–50%, stop -30%. Rationale: M&A-driven re-rating in energy/chemicals and consolidation optionality given increased buyer appetite from strategic acquirers; hold through integration catalysts.
• Long CB (Chubb) — 9–15 month trade. Size 1–2% portfolio. Target +20–30%, stop -18%. Rationale: insurance sector consolidation and strategic interest from conglomerates raise takeover floor and relative multiple expansion.
• Pair trade — Long AAPL + INTC, Short BRKB (equal $ exposure) — 12–24 month trade. Net size 3–6% portfolio. Target relative outperformance of tech basket vs BRKB by 15–25%, stop relative loss of 12%. Rationale: capture secular tech multiple expansion while hedging conglomerate governance/asset-allocation drag.
• Contrarian hedge — Small long BRKB (3% portfolio) using Jan-2028 LEAPs/stock. Target conservative +25–40% over 24–36 months, stop trim at -20%. Rationale: hedge for scenario where Abel’s operating M&A substantially lifts ROIC and book value; keeps asymmetric long exposure with limited capital outlay.